Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kostiantyn Shabelnyk

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|June 13, 2025
In Silico Identification and Characterization of Spiro[1,2,4]triazolo[1,5-<i>c</i>]quinazolines as Diacylglycerol Kinase α ModulatorsLyudmyla Antypenko, Kostiantyn Shabelnyk, Oleksii Antypenko, et al.
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|January 23, 2026
Novel pyrazole bearing heterocyclic hybrids as promising biologically active compoundsKostiantyn Shabelnyk, Yevhen Zaika, Dmytro Skoryna, et al.
Journal of Neurochemistry|January 5, 2026
Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo EvaluationKostiantyn Shabelnyk, Lyudmyla Antypenko, Natalia Bohdan, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolinesOleksandr Grytsak, Kostiantyn Shabelnyk, Hanna Severina, et al.
Archiv Der Pharmazie|August 30, 2019
Synthesis and mode of action studies of novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines to combat pathogenic fungiLyudmyla Antypenko, Zhanar Sadykova, Kostiantyn Shabelnyk, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and ActivityKostiantyn Shabelnyk, Alina Fominichenko, Oleksii Antypenko, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|June 13, 2025
In Silico Identification and Characterization of Spiro[1,2,4]triazolo[1,5-<i>c</i>]quinazolines as Diacylglycerol Kinase α ModulatorsLyudmyla Antypenko, Kostiantyn Shabelnyk, Oleksii Antypenko, et al.
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|January 23, 2026
Novel pyrazole bearing heterocyclic hybrids as promising biologically active compoundsKostiantyn Shabelnyk, Yevhen Zaika, Dmytro Skoryna, et al.
Journal of Neurochemistry|January 5, 2026
Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo EvaluationKostiantyn Shabelnyk, Lyudmyla Antypenko, Natalia Bohdan, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolinesOleksandr Grytsak, Kostiantyn Shabelnyk, Hanna Severina, et al.
Archiv Der Pharmazie|August 30, 2019
Synthesis and mode of action studies of novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines to combat pathogenic fungiLyudmyla Antypenko, Zhanar Sadykova, Kostiantyn Shabelnyk, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and ActivityKostiantyn Shabelnyk, Alina Fominichenko, Oleksii Antypenko, et al.
Pageof 1